Immunovant Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -389.7% | -389.7% | -206.8% |
| FY2020 | -70.6% | -70.6% | -60.7% |
| FY2021 | -27.4% | -27.4% | -26.0% |
| FY2022 | -33.4% | -33.4% | -30.4% |
| FY2023 | -58.2% | -58.2% | -52.0% |
| FY2024 | -42.0% | -42.0% | -38.9% |
| FY2025 | -58.5% | -58.5% | -53.3% |
| FY2026 | -59.3% | -59.3% | -52.8% |